Saturday 17 October 2026
Export WAT’s income statement to Excel — free account
Waters Corporation
WAT Healthcare Diagnostics & Research
Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024. In the quarter to June 2026, revenue grew 113.4%, EPS fell 156.3%, free cash flow grew 750.0% and total debt rose 308.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
436.95
7.20
−1.62%
Follow WAT
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
32.96% | 29.27% | 5.21% | 1.92% | |
Piotroski F-Score |
6 | 5 | 2 | 4 | |
| 13.83% | 13.35% | 3.09% | 1.13% | ||
ROIC |
18.28% | 17.17% | 1.92% | 1.05% | |
Return on Tangible Assets |
49.69% | 41.43% | 13.58% | 4.69% | |
Average Days of Receivables |
87.97 | 95.59 | 169.71 | 156.16 | |
Free Cash Flow per Share |
10.12 | 8.53 | 2.82 | 3.73 | |
Free Cash Flow |
602.27 | 507.60 | 231.60 | 366.60 | |
Capital Expenditures |
(125.88) | (144.96) | (157.96) | (182.96) | |
| Other line items | |||||
Cash ROIC |
16.12% | 12.39% | 1.12% | 1.78% | |
Accounts Receivable Turnover |
4.38 | 4.05 | 3.06 | 3.42 | |
Accounts Payable Turnover |
12.12 | 12.64 | 4.80 | 4.75 | |
Inventory Turnover |
2.33 | 2.46 | 1.68 | 2.38 | |
Average Days of Payables |
33.15 | 29.45 | 129.95 | 138.11 | |
Days of Inventory on Hand |
164.11 | 161.99 | 322.94 | 220.36 | |
Tax Rate |
(0.16) | (0.15) | (0.14) | (0.19) | |
Research and Development Expense of Revenue |
6.33% | 6.18% | 6.49% | 6.84% | |
Selling, General and Administrative Expense of Revenue |
24.46% | 26.23% | 27.67% | 26.92% | |
Share Based Compensation of Revenue |
1.65% | 1.71% | 1.62% | 1.57% | |
Interest Coverage |
11.05 | 11.54 | 5.83 | 2.22 | |
Operating CF/Net income |
1.12 | 1.02 | 0.87 | 3.30 | |
Depreciation/Fixed assets |
0.32 | 0.32 | 0.24 | 0.41 | |
Capex/Depreciation |
(0.62) | (0.70) | (0.43) | (0.30) | |
Revenue per Share |
52.17 | 53.19 | 45.90 | 47.29 | |
Operating CF per Share |
12.23 | 10.97 | 4.74 | 5.60 | |
Capex per Share |
(2.11) | (2.44) | (1.92) | (1.86) | |
Capex to Sales |
0.04 | 0.05 | 0.04 | 0.04 |
Columns are period end dates